186 related articles for article (PubMed ID: 8391247)
1. SCH 38057: a picornavirus capsid-binding molecule with antiviral activity after the initial stage of viral uncoating.
Rozhon E; Cox S; Buontempo P; O'Connell J; Slater W; De Martino J; Schwartz J; Miller G; Arnold E; Zhang A
Antiviral Res; 1993 May; 21(1):15-35. PubMed ID: 8391247
[TBL] [Abstract][Full Text] [Related]
2. Antipicornavirus activity of SCH 47802 and analogs: in vitro and in vivo studies.
Cox S; Buontempo PJ; Wright-Minogue J; DeMartino JL; Skelton AM; Ferrari E; Schwartz J; Rozhon EJ; Linn CC; Girijavallabhan V; O'Connell JF
Antiviral Res; 1996 Oct; 32(2):71-9. PubMed ID: 8891166
[TBL] [Abstract][Full Text] [Related]
3. Structure determination of antiviral compound SCH 38057 complexed with human rhinovirus 14.
Zhang A; Nanni RG; Li T; Arnold GF; Oren DA; Jacobo-Molina A; Williams RL; Kamer G; Rubenstein DA; Li Y
J Mol Biol; 1993 Apr; 230(3):857-67. PubMed ID: 8386772
[TBL] [Abstract][Full Text] [Related]
4. The site of attachment in human rhinovirus 14 for antiviral agents that inhibit uncoating.
Smith TJ; Kremer MJ; Luo M; Vriend G; Arnold E; Kamer G; Rossmann MG; McKinlay MA; Diana GD; Otto MJ
Science; 1986 Sep; 233(4770):1286-93. PubMed ID: 3018924
[TBL] [Abstract][Full Text] [Related]
5. SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity.
Rosenwirth B; Oren DA; Arnold E; Kis ZL; Eggers HJ
Antiviral Res; 1995 Jan; 26(1):65-82. PubMed ID: 7741522
[TBL] [Abstract][Full Text] [Related]
6. Antiviral agents against picornaviruses.
Eggers HJ
Antiviral Res; 1985; Suppl 1():57-65. PubMed ID: 3002267
[No Abstract] [Full Text] [Related]
7. A novel basis of capsid stabilization by antiviral compounds.
Phelps DK; Post CB
J Mol Biol; 1995 Dec; 254(4):544-51. PubMed ID: 7500332
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activities of WIN 54954, a new broad-spectrum antipicornavirus drug.
Woods MG; Diana GD; Rogge MC; Otto MJ; Dutko FJ; McKinlay MA
Antimicrob Agents Chemother; 1989 Dec; 33(12):2069-74. PubMed ID: 2559655
[TBL] [Abstract][Full Text] [Related]
9. An antiviral compound that blocks structural transitions of poliovirus prevents receptor binding at low temperatures.
Dove AW; Racaniello VR
J Virol; 2000 Apr; 74(8):3929-31. PubMed ID: 10729171
[TBL] [Abstract][Full Text] [Related]
10. In vitro and in vivo antipicornavirus activity of some phenoxypyridinecarbonitriles.
Kenny MT; Dulworth JK; Torney HL
Antimicrob Agents Chemother; 1985 Dec; 28(6):745-50. PubMed ID: 2417545
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and activity of piperazine-containing antirhinoviral agents and crystal structure of SDZ 880-061 bound to human rhinovirus 14.
Oren DA; Zhang A; Nesvadba H; Rosenwirth B; Arnold E
J Mol Biol; 1996 May; 259(1):120-34. PubMed ID: 8648640
[TBL] [Abstract][Full Text] [Related]
12. SCH 48973: a potent, broad-spectrum, antienterovirus compound.
Buontempo PJ; Cox S; Wright-Minogue J; DeMartino JL; Skelton AM; Ferrari E; Albin R; Rozhon EJ; Girijavallabhan V; Modlin JF; O'Connell JF
Antimicrob Agents Chemother; 1997 Jun; 41(6):1220-5. PubMed ID: 9174174
[TBL] [Abstract][Full Text] [Related]
13. Prevention of rhinovirus and poliovirus uncoating by WIN 51711, a new antiviral drug.
Fox MP; Otto MJ; McKinlay MA
Antimicrob Agents Chemother; 1986 Jul; 30(1):110-6. PubMed ID: 3019232
[TBL] [Abstract][Full Text] [Related]
14. Use of drug-resistance mutants to identify functional regions in picornavirus capsid proteins.
Mosser AG; Shepard DA; Rueckert RR
Arch Virol Suppl; 1994; 9():111-9. PubMed ID: 8032243
[TBL] [Abstract][Full Text] [Related]
15. Method for detection of picornavirus capsid binders with soluble intercellular adhesion molecule 1.
Last-Barney K; Marlin SD; Pal K; Cahill-Feehan C; McNally EJ; Jeanfavre DD; Merluzzi VJ
Antimicrob Agents Chemother; 1993 Aug; 37(8):1693-5. PubMed ID: 8105750
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of WIN 51711, a new broad-spectrum antipicornavirus drug.
Otto MJ; Fox MP; Fancher MJ; Kuhrt MF; Diana GD; McKinlay MA
Antimicrob Agents Chemother; 1985 Jun; 27(6):883-6. PubMed ID: 2992365
[TBL] [Abstract][Full Text] [Related]
17. trans-encapsidation of a poliovirus replicon by different picornavirus capsid proteins.
Jia XY; Van Eden M; Busch MG; Ehrenfeld E; Summers DF
J Virol; 1998 Oct; 72(10):7972-7. PubMed ID: 9733835
[TBL] [Abstract][Full Text] [Related]
18. Structures of poliovirus complexes with anti-viral drugs: implications for viral stability and drug design.
Grant RA; Hiremath CN; Filman DJ; Syed R; Andries K; Hogle JM
Curr Biol; 1994 Sep; 4(9):784-97. PubMed ID: 7820548
[TBL] [Abstract][Full Text] [Related]
19. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M
Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495
[TBL] [Abstract][Full Text] [Related]
20. The refined structure of human rhinovirus 16 at 2.15 A resolution: implications for the viral life cycle.
Hadfield AT; Lee Wm; Zhao R; Oliveira MA; Minor I; Rueckert RR; Rossmann MG
Structure; 1997 Mar; 5(3):427-41. PubMed ID: 9083115
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
